💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
User | Tweets |
---|---|
@TShortalgo | 5 |
@StckPro | 3 |
@stock_titan | 2 |
@otcdynamics | 2 |
@PeterHa18329727 | 2 |
![]() |
@Tickeron $QGEN in Uptrend: price may jump up because it broke its lower Bollinger Band on February 21, 2023. View odds for t… https://t.co/5Eioa0lf65 March 19th 2023, 11:03pm |
![]() |
@Tickeron $QGEN in Uptrend: price expected to rise as it breaks its lower Bollinger Band on February 21, 2023. View odds for… https://t.co/Wmkc8dGQiE March 18th 2023, 2:03am |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Short signal. 64.29% Profitability based on 17 trades. Profit factor is 1.77. Learn… https://t.co/c2HLlJVh00 March 17th 2023, 8:03am |
![]() |
@Slayer10Stock $QGEN Awaiting Short Signal based off 10 signals $1,332 net profit 9.95 profit factor 80% win rate on a 15-min char… https://t.co/CDZ7DT1Zh7 March 15th 2023, 2:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Short signal. 71.43% Profitability based on 7 trades. Profit factor is 2.87. Learn m… https://t.co/5LPFTMa8gY March 14th 2023, 11:03am |
![]() |
@ainvest_vision AInvest Earnings Snapshot: ?? Qiagen N.V. $QGEN released FY earnings report. Sales: 2.14B -4.89%YOY ?? EPS: 1.86 -… https://t.co/LbdO9csHsv March 14th 2023, 12:03am |
![]() |
@TradeWithAlerts Nice print for $QGEN Size: 211791 Price: 46.42 Amount: $9,831,338.22 Time: 1830 See more: https://t.co/iir4RMeH5T J… https://t.co/KiRH7gwnlX March 13th 2023, 10:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Short signal. 66.67% Profitability based on 13 trades. Profit factor is 2.58. Learn… https://t.co/hVQjq8IOfC March 13th 2023, 7:03pm |
![]() |
@otcdynamics $QGEN QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results https://t.co/S9DAfgibMM March 13th 2023, 1:03pm |
![]() |
@otcdynamics $QGEN QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results https://t.co/Ew3CZrtmMh March 13th 2023, 12:03pm |
![]() |
@StockNewsBot2 $QGEN QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results https://t.co/7p09wMMNW0 March 13th 2023, 12:03pm |
![]() |
@stock_titan $QGEN QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results https://t.co/kFfpbUWekI March 13th 2023, 12:03pm |
![]() |
@DavidPe05712916 $qgen *Top analyst price target for next week ??? https://t.co/1f0P5PBQB5 March 13th 2023, 3:03am |
![]() |
@Anita58974246 $qgen *Top analyst price target for next week ??? https://t.co/uezGPeED7r March 12th 2023, 3:03am |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Buy signal. 83.33% Profitability based on 6 trades. Profit factor is 129. Learn more… https://t.co/LiSUCkvnie March 12th 2023, 2:03am |
![]() |
@1stOncology #QIAGEN and Servier partner to develop companion diagnostic for #AcuteMyeloidLeukemia (#AML) therapy drug $QGEN https://t.co/vhh4f3kYBA March 10th 2023, 12:03pm |
![]() |
@PeterHa18329727 $qgen *Top analyst price target for next week ??? https://t.co/UExIrvNw95 March 9th 2023, 4:03pm |
![]() |
@MarketCurrents $QGEN - Qiagen to develop companion diagnostic test for Servier's blood cancer drug Tibsovo https://t.co/PP7sXDer7c March 9th 2023, 11:03am |
![]() |
@algobotnews Qiagen enters strategic partnership with Servier $QGEN March 9th 2023, 10:03am |
![]() |
@PeterHa18329727 $qgen Top analyst price target for next week ??? https://t.co/UExIrvNw95 March 9th 2023, 9:03am |
![]() |
@StckPro $QGEN NEW ARTICLE : QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) The… https://t.co/jdf0P76OSx March 9th 2023, 7:03am |
![]() |
@StckPro $QGEN NEW ARTICLE : QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) The… https://t.co/rENSenj3uC March 9th 2023, 7:03am |
![]() |
@bthefirsttoknow First out// $QGEN: QIAGEN and Servier Unite to Develop Companion Diagnostic for Acute Myeloid Leukemia Therapy Drug https://t.co/hbTyyyNKos March 9th 2023, 7:03am |
![]() |
@StckPro $QGEN NEW ARTICLE : QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) The… https://t.co/aEf4LYFFwq March 9th 2023, 7:03am |
![]() |
@health_stocks QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug $QGEN https://t.co/rmvnkEL257 March 9th 2023, 6:03am |
![]() |
@BloombergFeed $QGEN QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug https://t.co/dKwIWCNa5u March 9th 2023, 6:03am |
![]() |
@StockNewsBot2 $QGEN QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug https://t.co/ex6dkL7iBP March 9th 2023, 6:03am |
![]() |
@newsfilterio QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia Therapy Drug $QGEN https://t.co/myJcuOwZcW March 9th 2023, 6:03am |
![]() |
@stock_titan $QGEN QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug https://t.co/WCvHctJQAs March 9th 2023, 6:03am |
![]() |
@WebChronicleTo1 $QGEN QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug https://t.co/xwWkxBxKl4 March 9th 2023, 6:03am |
![]() |
@Madelei30790030 $qgen *Top analyst price target for next week . ??? https://t.co/vHRAPIfurZ March 8th 2023, 3:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Buy signal. 83.33% Profitability based on 7 trades. Profit factor is 100. Learn more… https://t.co/GA7bTa7hXk March 8th 2023, 8:03am |
![]() |
@Slayer10Stock $QGEN Awaiting Buy Signal based off 9 signals $1,151 net profit 5.25 profit factor 77% win rate on a 15-min chart.… https://t.co/CS4nSyD4SH March 7th 2023, 2:03pm |
![]() |
@ShortAlgoKing $QGEN Trading Ideas | Awaiting Short signal. 75% Profitability based on 8 trades. Win rate is 22.81. #trading… https://t.co/SU6jnH4ITO March 7th 2023, 12:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Short signal. 75% Profitability based on 8 trades. Profit factor is 22.81. Learn mor… https://t.co/48NzmGUjd6 March 6th 2023, 11:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Short signal. 75% Profitability based on 8 trades. Profit factor is 22.81. Learn mor… https://t.co/nhNSN8Xnz6 March 5th 2023, 5:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Short signal. 75% Profitability based on 8 trades. Profit factor is 22.81. Learn mor… https://t.co/aWCiHwUAkT March 4th 2023, 9:03am |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Buy signal. 100% Profitability based on 7 trades. Profit factor is 100. Learn more a… https://t.co/NwMzORe1HB March 3rd 2023, 11:03am |
![]() |
@algobotnews Qiagen price target raised to EUR 56.90 from EUR 54.60 at Berenberg $QGEN March 2nd 2023, 8:03pm |
![]() |
@MarcJacksonLA $QGEN $SOPH Qiagen turns to Sophia Genetics to squeeze more data from next-gen sequencing tests https://t.co/oxw0kuC0wd March 2nd 2023, 1:03pm |
![]() |
@1stOncology #QIAGEN and #SOPHiAGENETICS forge partnership to combine strengths in next-generation sequencing $QGEN https://t.co/zapBOE63GT March 2nd 2023, 12:03pm |
![]() |
@TShortalgo $QGEN Trading Ideas | Awaiting Buy signal. 100% Profitability based on 6 trades. Profit factor is 100. Learn more a… https://t.co/pIT8SgIwZp March 2nd 2023, 9:03am |
![]() |
@otcdynamics $QGEN QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing https://t.co/gE1TPyCEV2 March 1st 2023, 6:03pm |
![]() |
@newsfilterio QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing $QGEN $SOPH https://t.co/hVV3wvU6HU March 1st 2023, 5:03pm |
![]() |
@newsfilterio SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing $QGEN $SOPH https://t.co/ENqp9Q8aYM March 1st 2023, 4:03pm |
![]() |
@health_stocks QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing $QGEN https://t.co/ZJhg6ArgWt March 1st 2023, 2:03pm |
![]() |
@TheTradeXchange $QGEN $SOPH: QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing March 1st 2023, 2:03pm |
![]() |
@StockNewsBot2 $SOPH $QGEN SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing https://t.co/mimtxNVi28 March 1st 2023, 2:03pm |
![]() |
@BloombergFeed $QGEN $SOPH QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing https://t.co/SEGmQ5vHsJ March 1st 2023, 2:03pm |
![]() |
@StockNewsBot2 $QGEN $SOPH QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing https://t.co/9UGjtblJK0 March 1st 2023, 2:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2023. All rights reserved.